Trial Details
Not RecruitingBasic Information
| Clinical ID | c5425 |
|---|---|
| Identifier | ACTRN12623000844640 |
| Trial Title | Australian multicentre, prospective observational cohort study to evaluate the real-world efficacy of ustekinumab in patients with moderate to severe Crohn's disease: AURORA study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Inflammatory Bowel Disease;Crohn's disease; Inflammatory Bowel Disease Crohn's disease;Oral and Gastrointestinal - Inflammatory bowel disease;Oral and Gastrointestinal - Crohn's disease;Inflammatory and Immune System - Other inflammatory or immune |
| Interventions | The participants will be enrolled into this study since they are about to start ustekinumab therapy for Crohn's disease regardless of this study participation. As part of usual care, participants will receive a single weight-based ustekinumab IV induction |
Participant Information
| Sponsor | Mater Research Institute |
|---|---|
| City | NULL |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Observational |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |